TheMachine Press

A daily newspaper for the age of artificial intelligence.

Morning editionPermanent story

research

Low Arginine Jammed the Cell's Antigen-Display Machinery

Cell and disease models show how scarcity of one amino acid can stall production of arginine-rich MHC-I proteins.

Published Updated Story ID: mp-2026-08-01-009
Read the complete editionStory JSON

Summary

Cell and disease models show how scarcity of one amino acid can stall production of arginine-rich MHC-I proteins.

Rockefeller University researchers report that low arginine stalls ribosomes while they translate arginine-rich MHC-I, or HLA, proteins, reducing the antigen display that helps immune cells spot threats. The team observed the mechanism in cell, cancer, influenza and SARS-CoV-2 models, and moderate supplementation rescued gene expression experimentally. The work is mechanistic and is not clinical advice to take arginine supplements.

Why it matters

Cell and disease models show how scarcity of one amino acid can stall production of arginine-rich MHC-I proteins.

Limits and context

  • The work is mechanistic and is not clinical advice to take arginine supplements.

Key claims

  1. Cell and disease models show how scarcity of one amino acid can stall production of arginine-rich MHC-I proteins.

    Qualification: The work is mechanistic and is not clinical advice to take arginine supplements.

    Evidence: source-2026-08-01-009

Sources

  1. Rockefeller University via Newswise: Arginine and MHC-I translationRockefeller University via Newswise · official announcement

Corrections

No corrections have been recorded for this story.